COLUMN GROUP L P

Insider Reports History

Location
San Francisco, CA
Signature
/s/ James Evangelista, as Attorney-in-fact for The Column Group, LP
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by COLUMN GROUP L P:

Company Role Class Num Shares Value Price $ Report Date Ownership
Nurix Therapeutics, Inc. 10%+ Owner Common Stock 1,394,333 $13,947,652 $10.00 05 May 2021 Direct
Nurix Therapeutics, Inc. 10%+ Owner Common Stock 48,406 $484,210 $10.00 05 May 2021 Indirect
NGM BIOPHARMACEUTICALS INC Director, 10%+ Owner Common Stock 1,000 $1,340 $1.34 05 Apr 2024 Indirect
NGM BIOPHARMACEUTICALS INC Director, 10%+ Owner Common Stock 0 $0 $1.34 05 Apr 2024 Direct

Insider Reports Filed by COLUMN GROUP L P

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000095014224001000-column-group-l-p-2024-04-05 NGM BIOPHARMACEUTICALS INC 05 Apr 2024 14 $0 4 Director, 10%+ Owner 08 Apr 2024, 20:03
/report/000095017023064858-column-group-l-p-2023-11-15 NGM BIOPHARMACEUTICALS INC 15 Nov 2023 2 +$15,507 4 Director, 10%+ Owner 17 Nov 2023, 16:33
/report/000095017023064854-column-group-l-p-2023-11-15 NGM BIOPHARMACEUTICALS INC 15 Nov 2023 2 +$15,507 4 Director, 10%+ Owner 17 Nov 2023, 16:30
/report/000095017023064847-column-group-l-p-2023-11-15 NGM BIOPHARMACEUTICALS INC 15 Nov 2023 2 +$15,507 4 Director, 10%+ Owner 17 Nov 2023, 16:28
/report/000089924323003137-column-group-l-p-2023-01-30 NGM BIOPHARMACEUTICALS INC 30 Jan 2023 2 +$921,110 4 Director, 10%+ Owner 01 Feb 2023, 15:50
/report/000089924323003132-column-group-l-p-2023-01-30 NGM BIOPHARMACEUTICALS INC 30 Jan 2023 2 +$921,110 4 Director, 10%+ Owner 01 Feb 2023, 15:31
/report/000089924323003130-column-group-l-p-2023-01-30 NGM BIOPHARMACEUTICALS INC 30 Jan 2023 2 +$921,110 4 Director, 10%+ Owner 01 Feb 2023, 15:29
/report/000089924323002642-column-group-l-p-2023-01-23 NGM BIOPHARMACEUTICALS INC 23 Jan 2023 1 +$49,494 4 Director, 10%+ Owner 25 Jan 2023, 15:38
/report/000089924323002637-column-group-l-p-2023-01-23 NGM BIOPHARMACEUTICALS INC 23 Jan 2023 1 +$49,494 4 Director, 10%+ Owner 25 Jan 2023, 15:35
/report/000089924323002630-column-group-l-p-2023-01-23 NGM BIOPHARMACEUTICALS INC 23 Jan 2023 1 +$49,494 4 Director, 10%+ Owner 25 Jan 2023, 15:31
/report/000089924323002381-column-group-l-p-2023-01-19 NGM BIOPHARMACEUTICALS INC 19 Jan 2023 2 +$190,603 4 Director, 10%+ Owner 23 Jan 2023, 15:25
/report/000089924323002380-column-group-l-p-2023-01-19 NGM BIOPHARMACEUTICALS INC 19 Jan 2023 2 +$190,603 4 Director, 10%+ Owner 23 Jan 2023, 15:22
/report/000089924323002375-column-group-l-p-2023-01-19 NGM BIOPHARMACEUTICALS INC 19 Jan 2023 2 +$190,603 4 Director, 10%+ Owner 23 Jan 2023, 15:19
/report/000089924323001857-column-group-l-p-2023-01-12 NGM BIOPHARMACEUTICALS INC 12 Jan 2023 1 +$26,603 4 Director, 10%+ Owner 17 Jan 2023, 15:36
/report/000089924323001855-column-group-l-p-2023-01-12 NGM BIOPHARMACEUTICALS INC 12 Jan 2023 1 +$26,603 4 Director, 10%+ Owner 17 Jan 2023, 15:34
/report/000089924323001854-column-group-l-p-2023-01-12 NGM BIOPHARMACEUTICALS INC 12 Jan 2023 1 +$26,603 4 Director, 10%+ Owner 17 Jan 2023, 15:32
/report/000089924323001697-column-group-l-p-2023-01-10 NGM BIOPHARMACEUTICALS INC 10 Jan 2023 2 +$1,479,359 4 Director, 10%+ Owner 12 Jan 2023, 15:40
/report/000089924323001695-column-group-l-p-2023-01-10 NGM BIOPHARMACEUTICALS INC 10 Jan 2023 2 +$1,479,359 4 Director, 10%+ Owner 12 Jan 2023, 15:37
/report/000089924323001694-column-group-l-p-2023-01-10 NGM BIOPHARMACEUTICALS INC 10 Jan 2023 2 +$1,479,359 4 Director, 10%+ Owner 12 Jan 2023, 15:35
/report/000089924322038468-column-group-l-p-2022-12-12 NGM BIOPHARMACEUTICALS INC 12 Dec 2022 1 +$1,493 4 Director, 10%+ Owner 14 Dec 2022, 15:31
/report/000089924322038466-column-group-l-p-2022-12-12 NGM BIOPHARMACEUTICALS INC 12 Dec 2022 1 +$1,493 4 Director, 10%+ Owner 14 Dec 2022, 15:29
/report/000089924322038465-column-group-l-p-2022-12-12 NGM BIOPHARMACEUTICALS INC 12 Dec 2022 1 +$1,493 4 Director, 10%+ Owner 14 Dec 2022, 15:28
/report/000089924322036919-column-group-l-p-2022-11-21 NGM BIOPHARMACEUTICALS INC 21 Nov 2022 2 +$201,588 4 Director, 10%+ Owner 23 Nov 2022, 15:21
/report/000089924322036916-column-group-l-p-2022-11-21 NGM BIOPHARMACEUTICALS INC 21 Nov 2022 2 +$201,588 4 Director, 10%+ Owner 23 Nov 2022, 15:17
/report/000089924322036912-column-group-l-p-2022-11-21 NGM BIOPHARMACEUTICALS INC 21 Nov 2022 2 +$201,588 4 Director, 10%+ Owner 23 Nov 2022, 15:14
/report/000089924322035279-column-group-l-p-2022-11-03 NGM BIOPHARMACEUTICALS INC 03 Nov 2022 2 +$684,427 4 Director, 10%+ Owner 07 Nov 2022, 15:30
/report/000089924322035277-column-group-l-p-2022-11-03 NGM BIOPHARMACEUTICALS INC 03 Nov 2022 2 +$684,427 4 Director, 10%+ Owner 07 Nov 2022, 15:20
/report/000089924322035274-column-group-l-p-2022-11-03 NGM BIOPHARMACEUTICALS INC 03 Nov 2022 2 +$684,427 4 Director, 10%+ Owner 07 Nov 2022, 15:17
/report/000089924322034563-column-group-l-p-2022-10-27 NGM BIOPHARMACEUTICALS INC 27 Oct 2022 1 +$373,638 4 Director, 10%+ Owner 31 Oct 2022, 17:20
/report/000089924322034562-column-group-l-p-2022-10-27 NGM BIOPHARMACEUTICALS INC 27 Oct 2022 1 +$373,638 4 Director, 10%+ Owner 31 Oct 2022, 17:19
/report/000089924322034559-column-group-l-p-2022-10-27 NGM BIOPHARMACEUTICALS INC 27 Oct 2022 1 +$373,638 4 Director, 10%+ Owner 31 Oct 2022, 17:17
/report/000089924322034360-column-group-l-p-2022-10-25 NGM BIOPHARMACEUTICALS INC 25 Oct 2022 2 +$595,428 4 Director, 10%+ Owner 27 Oct 2022, 18:58
/report/000089924322034359-column-group-l-p-2022-10-25 NGM BIOPHARMACEUTICALS INC 25 Oct 2022 2 +$595,428 4 Director, 10%+ Owner 27 Oct 2022, 18:55
/report/000089924322034352-column-group-l-p-2022-10-25 NGM BIOPHARMACEUTICALS INC 25 Oct 2022 2 +$595,428 4 Director, 10%+ Owner 27 Oct 2022, 18:50
/report/000089924322022214-column-group-l-p-2022-06-09 NGM BIOPHARMACEUTICALS INC 09 Jun 2022 2 +$13,286,174 4 Director, 10%+ Owner 13 Jun 2022, 17:05
/report/000089924322022212-column-group-l-p-2022-06-09 NGM BIOPHARMACEUTICALS INC 09 Jun 2022 2 +$13,286,174 4 Director, 10%+ Owner 13 Jun 2022, 16:58
/report/000089924322021216-column-group-l-p-2022-06-02 NGM BIOPHARMACEUTICALS INC 02 Jun 2022 2 +$445,739 4 Director, 10%+ Owner 06 Jun 2022, 16:44
/report/000089924322021215-column-group-l-p-2022-06-02 NGM BIOPHARMACEUTICALS INC 02 Jun 2022 2 +$445,739 4 Director, 10%+ Owner 06 Jun 2022, 16:43
/report/000089924322020690-column-group-l-p-2022-05-31 NGM BIOPHARMACEUTICALS INC 31 May 2022 4 +$2,069,667 4 Director, 10%+ Owner 02 Jun 2022, 16:28
/report/000089924322020688-column-group-l-p-2022-05-31 NGM BIOPHARMACEUTICALS INC 31 May 2022 4 +$2,069,667 4 Director, 10%+ Owner 02 Jun 2022, 16:26
/report/000089924322020203-column-group-l-p-2022-05-26 NGM BIOPHARMACEUTICALS INC 26 May 2022 4 +$309,035 4 Director, 10%+ Owner 31 May 2022, 17:02
/report/000089924322020202-column-group-l-p-2022-05-26 NGM BIOPHARMACEUTICALS INC 26 May 2022 4 +$309,035 4 Director, 10%+ Owner 31 May 2022, 16:59
/report/000089924322019690-column-group-l-p-2022-05-24 NGM BIOPHARMACEUTICALS INC 24 May 2022 4 +$819,948 4 Director, 10%+ Owner 26 May 2022, 16:13
/report/000089924322019689-column-group-l-p-2022-05-24 NGM BIOPHARMACEUTICALS INC 24 May 2022 4 +$819,948 4 Director, 10%+ Owner 26 May 2022, 16:11
/report/000089924322019209-column-group-l-p-2022-05-19 NGM BIOPHARMACEUTICALS INC 19 May 2022 4 +$530,454 4 Director, 10%+ Owner 23 May 2022, 16:14
/report/000089924322019208-column-group-l-p-2022-05-19 NGM BIOPHARMACEUTICALS INC 19 May 2022 4 +$530,454 4 Director, 10%+ Owner 23 May 2022, 16:12
/report/000089924322018849-column-group-l-p-2022-05-17 NGM BIOPHARMACEUTICALS INC 17 May 2022 4 +$2,022,004 4 Director, 10%+ Owner 19 May 2022, 16:39
/report/000089924322018848-column-group-l-p-2022-05-17 NGM BIOPHARMACEUTICALS INC 17 May 2022 4 +$2,022,004 4 Director, 10%+ Owner 19 May 2022, 16:35
/report/000089924322018401-column-group-l-p-2022-05-13 NGM BIOPHARMACEUTICALS INC 13 May 2022 4 +$427,891 4 Director, 10%+ Owner 17 May 2022, 16:22
/report/000089924322018399-column-group-l-p-2022-05-13 NGM BIOPHARMACEUTICALS INC 13 May 2022 4 +$427,891 4 Director, 10%+ Owner 17 May 2022, 16:21
/report/000089924322018031-column-group-l-p-2022-05-11 NGM BIOPHARMACEUTICALS INC 11 May 2022 8 +$1,902,032 4 Director, 10%+ Owner 13 May 2022, 17:32
/report/000089924322018030-column-group-l-p-2022-05-11 NGM BIOPHARMACEUTICALS INC 11 May 2022 8 +$1,902,032 4 Director, 10%+ Owner 13 May 2022, 17:30
/report/000089924322017674-column-group-l-p-2022-05-09 NGM BIOPHARMACEUTICALS INC 09 May 2022 4 +$1,252,982 4 Director, 10%+ Owner 11 May 2022, 18:14
/report/000089924322017672-column-group-l-p-2022-05-09 NGM BIOPHARMACEUTICALS INC 09 May 2022 4 +$1,252,982 4 Director, 10%+ Owner 11 May 2022, 18:03
/report/000089924322003320-column-group-l-p-2022-01-24 NGM BIOPHARMACEUTICALS INC 24 Jan 2022 4 $0 4 Director, 10%+ Owner 26 Jan 2022, 18:14
/report/000089924322003318-column-group-l-p-2022-01-24 NGM BIOPHARMACEUTICALS INC 24 Jan 2022 4 $0 4 Director, 10%+ Owner 26 Jan 2022, 18:12
NRIX Nurix Therapeutics, Inc. 07 May 2021 15 $0 4 10%+ Owner 07 May 2021, 20:50
NRIX Nurix Therapeutics, Inc. 07 May 2021 15 $0 4 10%+ Owner 07 May 2021, 20:40